Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review
Anne Birgitte Simonsen, Jeanette Kaae, Eva Ellebæk, Inge Marie Svane, Claus Zachariae
Topics & Concepts
PembrolizumabMedicineNivolumabAdverse effectDermatologyProgrammed cell death 1Skin reactionImmunotherapyDrug reactionMonoclonalMonoclonal antibodyIntensive care medicineImmunologyAntibodyInternal medicineCancerDrugPharmacologyPD-L1Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchColorectal Cancer Treatments and Studies